Efficacy and safety of long-acting injectable paliperidone palmitate 1-month and 3-month formulations in the maintenance treatment of schizophrenia: a single-arm, open-label, interventional study in Rwandan healthcare settings.
Saved in:
| Title: | Efficacy and safety of long-acting injectable paliperidone palmitate 1-month and 3-month formulations in the maintenance treatment of schizophrenia: a single-arm, open-label, interventional study in Rwandan healthcare settings. |
|---|---|
| Authors: | Bizoza R; Ndera Neuro Psychiatric Teaching Hospital, University of Rwanda, Kigali, Rwanda., Mehawej J; Johnson & Johnson, Titusville, New Jersey, USA., Musoni-Rwililiza E; University Teaching Hospital of Kigali (CHUK), University of Rwanda, Kigali, Rwanda.; School of Medicine and Pharmacy, University of Rwanda, Kigali, Rwanda., Alphs L; Larry Alphs Consulting, Princeton, New Jersey, USA., Turkoz I; Johnson & Johnson, Titusville, New Jersey, USA., Sun L; Cytel, Cambridge, Massachusetts, USA., Killion L; Johnson & Johnson, Horsham, Pennsylvania, USA., Decotelli-Mendes C; Johnson & Johnson, Raritan, New Jersey, USA., Knight RK; Johnson & Johnson, Titusville, New Jersey, USA KKnight@its.jnj.com. |
| Source: | BMJ open [BMJ Open] 2026 Jun 16; Vol. 16 (6), pp. e109753. Date of Electronic Publication: 2026 Jun 16. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2044-6055 |
|---|---|
| DOI: | 10.1136/bmjopen-2025-109753 |
